Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Wasserman

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Allergy and Asthma Proceedings|December 6, 2021
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatmentRichard L Wasserman
The Journal of Allergy and Clinical Immunology. Global|February 3, 2025
Correspondence re: Long-term efficacy and safety of cow's milk anaphylaxis specific immunotherapy: Allergen unresponsiveness via the Tolerance Induction ProgramRichard L Wasserman
Advances in Therapy|March 4, 2020
Clinical Practice Experience with HyQvia in Adults Using Alternative Dosing Regimens and Pediatric Patients: A Retrospective StudyRichard L Wasserman,
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2020
Common variable immunodeficiency and respiratory complications: take-home messages for the clinicianRichard L Wasserman
Frontiers in Allergy|November 24, 2025
Editorial: Prediction of severity of food allergyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 3, 2018
Balancing the risks and burdens of food allergen avoidanceRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 3, 2019
Captaining the PIDD shipRichard L Wasserman
Expert Review of Clinical Immunology|February 18, 2014
A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiencyRichard L Wasserman
Journal of Clinical Immunology|July 26, 2012
Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back againRichard L Wasserman
Journal of Food Allergy|July 18, 2024
Long term oral immunotherapy management and assessment of successRichard L Wasserman
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Allergy and Asthma Proceedings|December 6, 2021
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatmentRichard L Wasserman
The Journal of Allergy and Clinical Immunology. Global|February 3, 2025
Correspondence re: Long-term efficacy and safety of cow's milk anaphylaxis specific immunotherapy: Allergen unresponsiveness via the Tolerance Induction ProgramRichard L Wasserman
Advances in Therapy|March 4, 2020
Clinical Practice Experience with HyQvia in Adults Using Alternative Dosing Regimens and Pediatric Patients: A Retrospective StudyRichard L Wasserman,
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2020
Common variable immunodeficiency and respiratory complications: take-home messages for the clinicianRichard L Wasserman
Frontiers in Allergy|November 24, 2025
Editorial: Prediction of severity of food allergyRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 3, 2018
Balancing the risks and burdens of food allergen avoidanceRichard L Wasserman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 3, 2019
Captaining the PIDD shipRichard L Wasserman
Expert Review of Clinical Immunology|February 18, 2014
A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiencyRichard L Wasserman
Journal of Clinical Immunology|July 26, 2012
Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back againRichard L Wasserman
Journal of Food Allergy|July 18, 2024
Long term oral immunotherapy management and assessment of successRichard L Wasserman
Pageof 10